Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis
Author:
Publisher
Frontiers Media SA
Subject
Transplantation
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1432-2277.2007.00477.x/fullpdf
Reference30 articles.
1. Mechanisms of Disease: focal segmental glomerulosclerosis
2. Recurrent glomerulonephritis following renal transplantation: an update
3. Circulating Factor Associated with Increased Glomerular Permeability to Albumin in Recurrent Focal Segmental Glomerulosclerosis
4. Plasmapheresis Reduces Proteinuria and Serum Capacity to Injure Glomeruli in Patients With Recurrent Focal Glomerulosclerosis
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin;Kidney International Reports;2022-01
2. Cyclophosphamide as a Treatment for Focal Segmental Glomerular Sclerosis Recurrence in a Kidney Transplant Patient;American Journal of Case Reports;2021-02-04
3. Experience of application of rituximab with resistant focal-segmental glomerulosclerosis in adults: a series of observations and a brief review of literature;Nephrology (Saint-Petersburg);2020-02-08
4. Glomerular C4d deposition can precede the development of focal segmental glomerulosclerosis;Kidney International;2019-09
5. Ablative Therapy in 2016 for Small Renal Masses;Urology & Nephrology Open Access Journal;2017-01-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3